Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-26 @ 1:59 AM
Study NCT ID:
NCT04646005
Status:
COMPLETED
Last Update Posted:
2025-09-08
First Post:
2020-11-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy
Sponsor:
Regeneron Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-28
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-29
Completion Date Type:
ACTUAL
First Submit Date:
2020-11-20
First Submit QC Date:
None
Study First Post Date:
2020-11-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-15
Results First Submit QC Date:
None
Results First Post Date:
2024-09-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-04
Last Update Post Date:
2025-09-08
Last Update Post Date Type:
ESTIMATED